SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) |
6 Months Ended | ||||
|---|---|---|---|---|---|
|
Jun. 30, 2026
USD ($)
|
Jun. 30, 2026
CNY (¥)
|
Jun. 30, 2025
USD ($)
|
Dec. 31, 2025
USD ($)
|
Dec. 31, 2023 |
|
| Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] | |||||
| Description of foreign currency translation adjustment | Consolidated Balance Sheets amounts, with the exception of equity, on June 30, 2026 and December 31, 2025 were translated at RMB6.7851 to $1.00 and RMB6.9931 to $1.00, respectively. Equity accounts were stated at their historical rates. The average translation rates applied to Consolidated Statements of Operations and Comprehensive Income and Cash Flows for the six months ended June 30, 2026 and 2025 were RMB6.8624 to $1.00 and RMB7.2526 to $1.00, respectively. | Consolidated Balance Sheets amounts, with the exception of equity, on June 30, 2026 and December 31, 2025 were translated at RMB6.7851 to $1.00 and RMB6.9931 to $1.00, respectively. Equity accounts were stated at their historical rates. The average translation rates applied to Consolidated Statements of Operations and Comprehensive Income and Cash Flows for the six months ended June 30, 2026 and 2025 were RMB6.8624 to $1.00 and RMB7.2526 to $1.00, respectively. | |||
| Investment fair value disclosure | $ 49,962 | $ 747,709 | |||
| Inventory write-down | 0 | $ 0 | |||
| Amortization of intangible assets | 194,756 | 315,320 | |||
| Advances from customers | 3,239,888 | 2,067,018 | |||
| Revenues recognized from contract liabilities | 1,579,660 | 1,143,860 | |||
| Research and development expense | 1,320,313 | $ 1,053,921 | |||
| Underpayment of taxes | $ 14,739 | ¥ 100,000 | |||
| Software, In-Development, Internally Developed, and Purchased [Member] | |||||
| Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] | |||||
| Intangible assets, estimated useful life | 3 years | 3 years | |||
| Publicly Traded Stocks [Member] | |||||
| Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] | |||||
| Investment fair value disclosure | $ 49,962 | $ 747,709 | |||
| Investment | 46,698 | ||||
| Unrealized gain on investments | $ 3,264 | ||||
| X | ||||||||||
- Definition Amount of amortization expense for finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Useful life of finite-lived intangible asset, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Describes the nature of the translation adjustment. Includes an analysis of the change during the period in the accumulated adjustment and explanation of items creating the change. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of estimated penalties recognized in the period arising from income tax examinations. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all investments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of unrealized gain (loss) on investment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|